Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Self-other recognition impairments in individuals with schizophrenia: a new experimental paradigm using a double mirror.

Keromnes G, Motillon T, Coulon N, Berthoz A, Du Boisgueheneuc F, Wehrmann M, Martin B, Thirioux B, Bonnot O, Ridereau R, Bellissant E, Drapier D, Levoyer D, Jaafari N, Tordjman S.

NPJ Schizophr. 2018 Nov 28;4(1):24. doi: 10.1038/s41537-018-0065-5.

2.

Hormonal Risk Factors for Osteoporosis: Different Profile Among Antipsychotics.

Raffin M, Bonnot O, Giannitelli M, Xavier J, Bodeau N, Bibrac B, Leban M, Fautrel B, Menard ML, Consoli A, Cohen D.

J Child Adolesc Psychopharmacol. 2018 Nov 13. doi: 10.1089/cap.2017.0158. [Epub ahead of print]

PMID:
30421978
3.

Psychiatric Disorders Secondary to Neurometabolic Disorders.

Herrera PM, Vélez Van Meerbeke A, Bonnot O.

Rev Colomb Psiquiatr. 2018 Oct - Dec;47(4):244-251. doi: 10.1016/j.rcp.2017.05.004. Epub 2017 Jun 17. Review. English, Spanish.

PMID:
30286847
4.

Systematic review of psychiatric signs in Niemann-Pick disease type C.

Bonnot O, Klünemann HH, Velten C, Torres Martin JV, Walterfang M.

World J Biol Psychiatry. 2018 Mar 12:1-13. doi: 10.1080/15622975.2018.1441548. [Epub ahead of print]

PMID:
29457916
5.

Recommendations for the detection and diagnosis of Niemann-Pick disease type C: An update.

Patterson MC, Clayton P, Gissen P, Anheim M, Bauer P, Bonnot O, Dardis A, Dionisi-Vici C, Klünemann HH, Latour P, Lourenço CM, Ory DS, Parker A, Pocoví M, Strupp M, Vanier MT, Walterfang M, Marquardt T.

Neurol Clin Pract. 2017 Dec;7(6):499-511. doi: 10.1212/CPJ.0000000000000399. Review.

6.

Psychiatric and neurological symptoms in patients with Niemann-Pick disease type C (NP-C): Findings from the International NPC Registry.

Bonnot O, Gama CS, Mengel E, Pineda M, Vanier MT, Watson L, Watissée M, Schwierin B, Patterson MC.

World J Biol Psychiatry. 2017 Oct 9:1-10. doi: 10.1080/15622975.2017.1379610. [Epub ahead of print]

PMID:
28914127
7.

Autism spectrum disorder: an early and frequent feature in cerebrotendinous xanthomatosis.

Stelten BML, Bonnot O, Huidekoper HH, van Spronsen FJ, van Hasselt PM, Kluijtmans LAJ, Wevers RA, Verrips A.

J Inherit Metab Dis. 2018 Jul;41(4):641-646. doi: 10.1007/s10545-017-0086-7. Epub 2017 Sep 11.

PMID:
28894950
8.

The hidden Niemann-Pick type C patient: clinical niches for a rare inherited metabolic disease.

Hendriksz CJ, Anheim M, Bauer P, Bonnot O, Chakrapani A, Corvol JC, de Koning TJ, Degtyareva A, Dionisi-Vici C, Doss S, Duning T, Giunti P, Iodice R, Johnston T, Kelly D, Klünemann HH, Lorenzl S, Padovani A, Pocovi M, Synofzik M, Terblanche A, Then Bergh F, Topçu M, Tranchant C, Walterfang M, Velten C, Kolb SA.

Curr Med Res Opin. 2017 May;33(5):877-890. doi: 10.1080/03007995.2017.1294054. Epub 2017 Mar 2. Review.

PMID:
28276873
9.

Influence of socioeconomic status on antipsychotic prescriptions among youth in France.

Bonnot O, Dufresne M, Herrera P, Michaud E, Pivette J, Chaslerie A, Sauvaget A, Vigneau C.

BMC Psychiatry. 2017 Feb 28;17(1):82. doi: 10.1186/s12888-017-1232-3.

10.

Rationale and protocol for using a smartphone application to study autism spectrum disorders: SMARTAUTISM.

Bonnot O, Bonneau D, Doudard A, Duverger P.

BMJ Open. 2016 Nov 22;6(11):e012135. doi: 10.1136/bmjopen-2016-012135.

11.

Antidépresseur et suicidalité chez le sujet jeune : les effets pervers des "black box warnings".

Ferreri F, Mouchabac S, Bonnot O.

Rev Prat. 2016 Nov;66(9):989-992. French. No abstract available.

PMID:
30512369
12.

Oculomotor Impairments in Developmental Dyspraxia.

Gaymard B, Giannitelli M, Challes G, Rivaud-Péchoux S, Bonnot O, Cohen D, Xavier J.

Cerebellum. 2017 Apr;16(2):411-420. doi: 10.1007/s12311-016-0817-6.

PMID:
27480770
13.

Time perception of simultaneous and sequential events in early-onset schizophrenia.

de Montalembert M, Coulon N, Cohen D, Bonnot O, Tordjman S.

Neurocase. 2016 Aug;22(4):392-9. doi: 10.1080/13554794.2016.1205098. Epub 2016 Jul 7.

PMID:
27388526
14.

Incidence of adverse events in antipsychotic-naïve children and adolescents treated with antipsychotic drugs: a French multicentre naturalistic study protocol (ETAPE).

Menard ML, Thümmler S, Giannitelli M, Olliac B, Bonnot O, Cohen D, Askenazy F; ETAPE Study group.

BMJ Open. 2016 Apr 6;6(4):e011020. doi: 10.1136/bmjopen-2015-011020.

15.

[Clinic of somatoform disorders in abused adolescents].

Marquis C, Vabres N, Caldagues E, Bonnot O.

Presse Med. 2016 Apr;45(4 Pt 1):e51-8. doi: 10.1016/j.lpm.2015.10.023. Epub 2016 Mar 23. French.

PMID:
27016848
16.

Health Care Trajectories for Children With ADHD in France: Results From the QUEST Survey.

Caci H, Cohen D, Bonnot O, Kabuth B, Raynaud JP, Paillé S, Vallée L.

J Atten Disord. 2016 Jan 21. pii: 1087054715618790. [Epub ahead of print]

PMID:
26794670
17.

[Time perception and schizophrenia: Phenomenological and neuropsychological approach].

de Montalembert M, Tordjman S, Bonnot O, Coulon N.

Encephale. 2015 Sep;41(4 Suppl 1):S56-61. doi: 10.1016/S0013-7006(15)30008-7. Review. French.

PMID:
26746324
18.

Psychotropic treatments in Prader-Willi syndrome: a critical review of published literature.

Bonnot O, Cohen D, Thuilleaux D, Consoli A, Cabal S, Tauber M.

Eur J Pediatr. 2016 Jan;175(1):9-18. doi: 10.1007/s00431-015-2670-x. Epub 2015 Nov 19. Review.

PMID:
26584571
19.

PHEDRE trial protocol - observational study of the prevalence of problematic use of Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) and analgesics in the French sickle-cell disease population.

Gérardin M, Couec ML, Grall-Bronnec M, Feuillet F, Wainstein L, Rousselet M, Pinot ML, Perrouin F, Bonnot O, Drouineau MH, Jolliet P, Victorri-Vigneau C.

BMC Psychiatry. 2015 Nov 14;15:281. doi: 10.1186/s12888-015-0677-5.

20.

[Treatable neurometabolic diseases. Association with schizophrenia spectrum disorders].

Bonnot O, Herrera P, Kuster A.

Presse Med. 2015 Sep;44(9):889-97. doi: 10.1016/j.lpm.2015.02.023. Epub 2015 Aug 3. Review. French.

PMID:
26248708
21.

Secondary psychosis induced by metabolic disorders.

Bonnot O, Herrera PM, Tordjman S, Walterfang M.

Front Neurosci. 2015 May 19;9:177. doi: 10.3389/fnins.2015.00177. eCollection 2015. Review.

22.

Autism as a disorder of biological and behavioral rhythms: toward new therapeutic perspectives.

Tordjman S, Davlantis KS, Georgieff N, Geoffray MM, Speranza M, Anderson GM, Xavier J, Botbol M, Oriol C, Bellissant E, Vernay-Leconte J, Fougerou C, Hespel A, Tavenard A, Cohen D, Kermarrec S, Coulon N, Bonnot O, Dawson G.

Front Pediatr. 2015 Feb 23;3:1. doi: 10.3389/fped.2015.00001. eCollection 2015. Review.

23.

[Improve safety monitoring of antipsychotics in the French pediatric population].

Menard ML, Askenazy F, Auby P, Bonnot O, Cohen D.

Arch Pediatr. 2015 Jan;22(1):92-7. doi: 10.1016/j.arcped.2014.10.011. Epub 2014 Nov 4. French.

PMID:
25482998
24.

Altered circadian patterns of salivary cortisol in low-functioning children and adolescents with autism.

Tordjman S, Anderson GM, Kermarrec S, Bonnot O, Geoffray MM, Brailly-Tabard S, Chaouch A, Colliot I, Trabado S, Bronsard G, Coulon N, Botbol M, Charbuy H, Camus F, Touitou Y.

Psychoneuroendocrinology. 2014 Dec;50:227-45. doi: 10.1016/j.psyneuen.2014.08.010. Epub 2014 Aug 27.

PMID:
25244637
25.

Gene × Environment interactions in autism spectrum disorders: role of epigenetic mechanisms.

Tordjman S, Somogyi E, Coulon N, Kermarrec S, Cohen D, Bronsard G, Bonnot O, Weismann-Arcache C, Botbol M, Lauth B, Ginchat V, Roubertoux P, Barburoth M, Kovess V, Geoffray MM, Xavier J.

Front Psychiatry. 2014 Aug 4;5:53. doi: 10.3389/fpsyt.2014.00053. eCollection 2014. Review.

26.

[Schizophrenic disorders in adolescence].

Bonnot O, Dumas N.

Rev Prat. 2014 Apr;64(4):499-504. French.

PMID:
24855785
27.

Diagnostic and treatment implications of psychosis secondary to treatable metabolic disorders in adults: a systematic review.

Bonnot O, Klünemann HH, Sedel F, Tordjman S, Cohen D, Walterfang M.

Orphanet J Rare Dis. 2014 Apr 28;9:65. doi: 10.1186/1750-1172-9-65. Review.

28.

Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges.

Glennon J, Purper-Ouakil D, Bakker M, Zuddas A, Hoekstra P, Schulze U, Castro-Fornieles J, Santosh PJ, Arango C, Kölch M, Coghill D, Flamarique I, Penzol MJ, Wan M, Murray M, Wong IC, Danckaerts M, Bonnot O, Falissard B, Masi G, Fegert JM, Vicari S, Carucci S, Dittmann RW, Buitelaar JK; PERS Consortium.

Eur Child Adolesc Psychiatry. 2014 Dec;23(12):1149-60. doi: 10.1007/s00787-013-0498-3. Epub 2013 Dec 15.

29.

[Safeguarding the prescription of antipsychotics in the paediatric population: A French multicentric study in a treatment naïve population].

Menard ML, Askénazy F, Auby P, Bonnot O, Cohen D.

Encephale. 2013 Oct;39(5):313-4. doi: 10.1016/j.encep.2013.03.005. Epub 2013 Jun 27. French. No abstract available.

PMID:
23809174
30.

The neuropsychiatry of inborn errors of metabolism.

Walterfang M, Bonnot O, Mocellin R, Velakoulis D.

J Inherit Metab Dis. 2013 Jul;36(4):687-702. doi: 10.1007/s10545-013-9618-y. Epub 2013 May 23. Review.

PMID:
23700255
31.

Children's synchrony and rhythmicity in imitation of peers: toward a developmental model of empathy.

Xavier J, Tilmont E, Bonnot O.

J Physiol Paris. 2013 Sep;107(4):291-7. doi: 10.1016/j.jphysparis.2013.03.012. Epub 2013 Apr 10. Review.

PMID:
23583461
32.

Adverse effects of second-generation antipsychotics in children and adolescents: a Bayesian meta-analysis.

Cohen D, Bonnot O, Bodeau N, Consoli A, Laurent C.

J Clin Psychopharmacol. 2012 Jun;32(3):309-16. doi: 10.1097/JCP.0b013e3182549259. Review.

PMID:
22544019
33.

Medical and developmental risk factors of catatonia in children and adolescents: a prospective case-control study.

Consoli A, Raffin M, Laurent C, Bodeau N, Campion D, Amoura Z, Sedel F, An-Gourfinkel I, Bonnot O, Cohen D.

Schizophr Res. 2012 May;137(1-3):151-8. doi: 10.1016/j.schres.2012.02.012. Epub 2012 Mar 7.

PMID:
22401837
34.

[Psychiatric and cognitive signs associated with inborn errors of metabolism].

Bonnot O, Cohen D.

Rev Neurol (Paris). 2011 Dec;167(12):881-5. doi: 10.1016/j.neurol.2011.03.014. Epub 2011 Oct 29. Review. French.

PMID:
22041824
35.

Are impairments of time perception in schizophrenia a neglected phenomenon?

Bonnot O, de Montalembert M, Kermarrec S, Botbol M, Walter M, Coulon N.

J Physiol Paris. 2011 Dec;105(4-6):164-9. doi: 10.1016/j.jphysparis.2011.07.006. Epub 2011 Jul 22. Review.

PMID:
21803155
36.

Malignant catatonia due to anti-NMDA-receptor encephalitis in a 17-year-old girl: case report.

Consoli A, Ronen K, An-Gourfinkel I, Barbeau M, Marra D, Costedoat-Chalumeau N, Montefiore D, Maksud P, Bonnot O, Didelot A, Amoura Z, Vidailhet M, Cohen D.

Child Adolesc Psychiatry Ment Health. 2011 May 13;5(1):15. doi: 10.1186/1753-2000-5-15.

37.

Children and adolescents with severe mental illness need vitamin D supplementation regardless of disease or treatment.

Bonnot O, Inaoui R, Raffin-Viard M, Bodeau N, Coussieu C, Cohen D.

J Child Adolesc Psychopharmacol. 2011 Apr;21(2):157-61. doi: 10.1089/cap.2010.0079. Epub 2011 Apr 12.

PMID:
21486172
38.

Modulation of brain β-endorphin concentration by the specific part of the Y chromosome in mice.

Botbol M, Roubertoux PL, Carlier M, Trabado S, Brailly-Tabard S, Perez-Diaz F, Bonnot O, Bronsard G, Tordjman S.

PLoS One. 2011 Mar 8;6(3):e16704. doi: 10.1371/journal.pone.0016704.

39.

Electroconvulsive therapy in adolescents with the catatonia syndrome: efficacy and ethics.

Consoli A, Benmiloud M, Wachtel L, Dhossche D, Cohen D, Bonnot O.

J ECT. 2010 Dec;26(4):259-65. doi: 10.1097/YCT.0b013e3181fb3924. Review.

PMID:
21099377
40.

Lorazepam, fluoxetine and packing therapy in an adolescent with pervasive developmental disorder and catatonia.

Consoli A, Gheorghiev C, Jutard C, Bodeau N, Kloeckner A, Pitron V, Cohen D, Bonnot O.

J Physiol Paris. 2010 Dec;104(6):309-14. doi: 10.1016/j.jphysparis.2010.09.002. Epub 2010 Oct 1.

PMID:
20888413
41.

Cerebrotendinous xanthomatosis presenting with severe externalized disorder: improvement after one year of treatment with chenodeoxycholic Acid.

Bonnot O, Fraidakis MJ, Lucanto R, Chauvin D, Kelley N, Plaza M, Dubourg O, Lyon-Caen O, Sedel F, Cohen D.

CNS Spectr. 2010 Apr;15(4):231-6.

PMID:
20414172
42.

Pain reactivity and plasma beta-endorphin in children and adolescents with autistic disorder.

Tordjman S, Anderson GM, Botbol M, Brailly-Tabard S, Perez-Diaz F, Graignic R, Carlier M, Schmit G, Rolland AC, Bonnot O, Trabado S, Roubertoux P, Bronsard G.

PLoS One. 2009 Aug 26;4(8):e5289. doi: 10.1371/journal.pone.0005289.

43.

Association of adolescent catatonia with increased mortality and morbidity: evidence from a prospective follow-up study.

Cornic F, Consoli A, Tanguy ML, Bonnot O, Périsse D, Tordjman S, Laurent C, Cohen D.

Schizophr Res. 2009 Sep;113(2-3):233-40. doi: 10.1016/j.schres.2009.04.021. Epub 2009 May 13.

PMID:
19443182
44.

Are patients with schizophrenia insensitive to pain? A reconsideration of the question.

Bonnot O, Anderson GM, Cohen D, Willer JC, Tordjman S.

Clin J Pain. 2009 Mar-Apr;25(3):244-52. doi: 10.1097/AJP.0b013e318192be97. Review.

PMID:
19333176
45.

[Schizophrenia and pain reactivity].

Bonnot O, Tordjman S.

Presse Med. 2008 Nov;37(11):1561-8. doi: 10.1016/j.lpm.2008.05.013. Epub 2008 Sep 6. Review. French.

PMID:
18774679
46.

Multidisciplinary approach of organic catatonia in children and adolescents may improve treatment decision making.

Lahutte B, Cornic F, Bonnot O, Consoli A, An-Gourfinkel I, Amoura Z, Sedel F, Cohen D.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1393-8. doi: 10.1016/j.pnpbp.2008.02.015. Epub 2008 Mar 7. Review.

PMID:
18417262
47.

[Drug treatment of early-onset schizophrenia].

Deniau E, Bonnot O, Cohen D.

Presse Med. 2008 May;37(5 Pt 2):853-8. doi: 10.1016/j.lpm.2008.01.014. Epub 2008 Mar 19. Review. French.

PMID:
18356007
48.

Does catatonia influence the phenomenology of childhood onset schizophrenia beyond motor symptoms?

Bonnot O, Tanguy ML, Consoli A, Cornic F, Graindorge C, Laurent C, Tordjman S, Cohen D.

Psychiatry Res. 2008 Apr 15;158(3):356-62. doi: 10.1016/j.psychres.2006.09.006. Epub 2008 Feb 12.

PMID:
18272234
49.

Priapism associated with sertraline.

Bonnot O, Warot D, Cohen D.

J Am Acad Child Adolesc Psychiatry. 2007 Jul;46(7):790-1. No abstract available.

PMID:
17581442
50.

Animal models relevant to schizophrenia and autism: validity and limitations.

Tordjman S, Drapier D, Bonnot O, Graignic R, Fortes S, Cohen D, Millet B, Laurent C, Roubertoux PL.

Behav Genet. 2007 Jan;37(1):61-78. Epub 2006 Dec 12. Review.

PMID:
17160702

Supplemental Content

Loading ...
Support Center